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LETTERS TO THE EDITOR
Urocanic Acid Binds to GABA but not to Histamine (H1, H2, or
H3) Receptors
To the Editor:
Urocanic acid (UCA) is a known epidermal component and a major
chromophore for ultraviolet (UV) light. Photoisomerization from trans-
to cis-UCA upon UV irradiation is thought to be an important event
initiating changes in immune functions. Recently, the UV-induced
suppression of local and systemic immune functions and generation
of antigen-specific tolerance have been attributed both to UCA
photoisomerization (reviewed by Norval, 1996) and to DNA damage
(reviewed by Vink et al, 1996). Although several experimental designs
have revealed stereospecific effects of the two isomers on intracellular
signaling, cytokine networks, and systemic immunity, a specific receptor
for UCA has not yet been discovered.
The conception that cis-UCA might act through histamine receptors
rests largely on indirect evidence obtained from experiments with
histamine receptor antagonists/agonists (Norval et al, 1990; Gilmour
et al, 1993a); however, the action of UCA through histaminergic
receptors in keratinocytes (Mitra et al, 1993), monocytes (Hart et al,
1993), and Langerhans cells (Beissert et al, 1997) has been rebutted.
Because of its structural relationship to γ-amino butyric acid (GABA),
UCA has also been included in screening of in vivo biologic activity
mediated by the GABA receptors, found typically in the central nervous
system, and substantial effectiveness was observed (Matheson et al,
1986, 1987). Direct competition binding studies with UCA have been
reported only on α2- and imidazol(in)e receptors
1 (no binding),
and GABA (weak binding with trans-UCA; cis-isomer not studied)
(Tunnicliff et al, 1985; Matheson et al, 1987).
In this study, we analyzed the binding of UCA isomers to the
histamine H1, H2, and H3 receptors, and to the GABA receptors in
radioligand competition assays in vitro. Cis-UCA was prepared from
trans-UCA (Aldrich) according to the method of Morrison et al (1980),
and purified by anion exchange column chromatography. The purity of
the isomers was checked with high performance liquid chromatography
(Pasanen et al, 1990) and [1H]NMR using DMSO-d6 as the solvent.
Experiments (n 5 16) with different batches of rat cortex membranes
were done, and the efficiency of UCA to displace bound radioligands
from H1- (n 5 3; [
3H]pyrilamine), H2- (n 5 6; [
3H]tiotidine), and
H3-(n 5 2; [
3H]R-α-methylhistamine) histamine receptors as well as
from GABA (n 5 5; [3H]GABA) receptors was studied (methods
reviewed by Enna et al, 1977; Hill, 1990). The specific receptor
binding was transformed into percentage of control (100% when no
competitor was present). The two UCA stereoisomers (ø1 mM of
UCA tested) did not show consistent displacement of H1, H2, or H3
binding. Thus no reliable IC50 values could be calculated for histamine
receptor binding. [3H]GABA binding was clearly displaced by non-
labeled GABA with an IC50 value of 58 nM and 95% confidence
interval (CI) from 46 to 72 nM. On the other hand, cis-UCA and
trans-UCA partially displaced [3H]GABA by 48% and 19%, respectively
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(Fig 1). Their S-shaped competition curves showed IC50 values of 51
and 38 µM for cis-UCA and trans-UCA, respectively (CI from 21 to
126 µM and from 3 to 532 µM, respectively). Thus, it is possible that the
UCA compounds displace GABA from subtypes of GABA receptors.
The binding data must be evaluated against the physiologic con-
centrations of UCA in the skin. The mean concentrations of UCA in
the unirradiated skin of a Caucasian population ranged between
2.3 and 62 nmol per cm2 (Jansen et al, 1991; Snellman et al, 1992,
1997; Gilmour et al, 1993b; Kavanagh et al, 1995), corresponding to
0.3–8.9 mM within the µ70 µm thick epidermis (Bruls et al, 1984).
When cis-UCA can be raised to 50% of the total epidermal UCA
concentrations with suberythemal doses of solar-simulated irradiation
(Snellman et al, 1997), the levels of cis-UCA in vivo are comparable
with the effective concentrations for GABA receptor binding in vitro.
Because these data did not show affinity of the UCA isomers to the
three histamine receptors, they suggest that the effects of UCA on
histaminergic functions must be indirect. Binding of trans-UCA (cis-
UCA not studied) to rat cortical membrane GABA receptors has been
reported, but it was much weaker than that of GABA (Matheson et al,
1987). Our data also show slight displacement of bound GABA by
trans-UCA, but a clearly stronger effect by cis-UCA. This is, to our
knowledge, the first report of interaction between cis-UCA and
GABA receptors.
Nerve fibers containing calcitonin gene-related peptide, a vaso-
dilating neurotransmitter, are intimately associated with epidermal
Langerhans cell bodies in mice (Hosoi et al, 1993). In other murine
systems, neurogenic mediators (e.g., calcitonin gene-related peptide,
Figure 1. Competition binding curves of cis-UCA, trans-UCA, and
GABA for [3H]GABA in the rat cortical membranes. Each curve includes
combined data from five separate binding experiments. The final [3H]GABA
concentration was 8 nM and the mean protein concentration was 1.13 mg per
ml. The IC50 values were determined by fitting the specific binding data to a
sigmoidal curve using GraphPad Prism 2.01 for Windows 95 (GraphPad
Software, San Diego, CA). The symbols (s, trans-UCA, n, cis-UCA, u,
GABA) and error bars represent the mean 6 SEM (n 5 3–10 for other data
except for controls where n 5 40).
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substance P, and nitric oxide) have also been shown to contribute to
UVB-induced erythema (Benrath et al, 1995), immunosuppression
(Gillardon et al, 1995), and production of cytokines like TNF-α in
mast cells (Ansel et al, 1993; Niizeki et al, 1997). Because GABA is an
inhibitory neurotransmitter, it might be possible that cis-UCA binds as
an antagonist to possible cutaneous GABA receptors. Such function
could disinhibit the secretion of cutaneous neuropeptides modulating
local immune reactions. Because no reports of GABA receptors in the
skin have been found, our next goal will be to study whether GABA
receptors exist in the skin.
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UV Immunosuppression and Skin Cancer
To the Editor:
We read with considerable interest the paper by Yamawaki et al
‘‘Genetic variation in low-dose UV-induced suppression of contact
hypersensitivity and in the skin photocarcinogenesis response,’’ pub-
lished in the Journal of Investigative Dermatology (109:716, 1997). The
data in Figs 4 and 5 of this paper compare tumor incidence and tumor
yield in C3H/HeN and C3H/HeJ mice treated with either UV alone
(Fig 4) or a single dose of UV followed by 12-O-tetradecanoyl-
phorbol-13-acetate promotion (Fig 5). These two mouse strains differ
in the Lps gene that is defective in C3H/HeJ mice and controls a
variety of B lymphocyte and macrophage responses. These mice
have also been reported to differ in susceptibility to the ‘‘local’’
immunosuppressive effects of UV radiation, proposed to be an import-
ant factor in UV carcinogenesis. We have some comments on this paper.
Statistical analysis It is stated (p. 719) that there are significant
differences in tumor incidence and yield between the two strains in
Fig 5, i.e., after treatment with UV and 12-O-tetradecanoyl-phorbol-
13-acetate, but not in Fig 4, i.e., after treatment with UV alone. By
visual inspection this would appear to be the case, but we were unable
to find any mention of any statistical test for significance. It is essential
to see the results of the application to this data, e.g., survival analysis
with censoring, which accounts for any tumor-free deaths during the
experiment, and appropriate statistical analysis, e.g., Kaplan–Meier
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logrank test, before it can be concluded that significant differences do
in fact exist.
Strain differences in UV immunosuppression There is not
universal agreement that C3H/HeN and C3H/HeJ strains do differ in
susceptibility to the immunosuppressive effects of UV. The UV dose–
responses for suppression of contact hypersensitivity in these two strains
are in fact identical if the ‘‘systemic’’ model is used (Noonan and De
Fabo, 1990) and would have predicted the findings in Fig 4.
‘‘Low-dose’’ versus ‘‘high-dose’’ immunosuppression It is simply
incorrect to say, as is stated in the Introduction (p. 716), that ‘‘A
relatively low dose of UV radiation is all that is required to produce
immunosuppression if the antigen is applied directly to the UV-exposed
skin site (local or low-dose immune suppression). On the other hand,
when a greater UV dose is administered, immunosuppression results
even if the antigen is applied to a non-UV exposed skin site (systemic
or high-dose immune suppression).’’
In fact, a direct comparison between UV-induced ‘‘local’’ and
‘‘systemic’’ immunosuppression of contact hypersensitivity showed that
the UV dose–responses for these effects are the same (Noonan and De
Fabo, 1990). The UV dose–responses differ, however, between mouse
strains (Noonan and De Fabo, 1990; Noonan and Hoffman, 1994) and
the kinetics of ‘‘local’’ and ‘‘systemic’’ suppression differ. A time lag of
2–3 d after UV before antigen application has long been known to be
necessary for the detection of systemic suppression (Noonan et al,
